Stereotactic body radiation therapy for the primary treatment of localized prostate cancer
2012 · Journal of Radiation Oncology · 74 citations
https://doi.org/10.1007/s13566-012-0067-2
C
Caspian Oliai
APLA Health(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
767
Papers
1.1K
Citations
16
h-index
27
i10-index
Caspian Oliai is an academic researcher from APLA Health. The author has contributed to research in topics: CAR-T cell therapy research & Lymphoma Diagnosis and Treatment & Acute Myeloid Leukemia Research. The author has an h-index of 16, co-authored 652 publications.
ORCID: 0000-0002-6368-8557Papers by this author
worksOutcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL
2024 · Journal of Clinical Oncology · 25 citations
https://doi.org/10.1200/jco.24.00321
Radioprotectants to reduce the risk of radiation-induced carcinogenesis
2013 · International Journal of Radiation Biology · 19 citations
https://doi.org/10.3109/09553002.2014.859762
Patient Characteristics and Outcomes of Outpatient Tisagenlecleucel Recipients for B Cell Non-Hodgkin Lymphoma
2023 · Transplantation and Cellular Therapy · 16 citations
https://doi.org/10.1016/j.jtct.2023.04.019
Anti-CD19 CAR T-cell therapy remission despite prior anti-CD19 antibody Tafasitamab in relapsed/refractory DLBCL
2021 · Leukemia Research Reports · 14 citations
https://doi.org/10.1016/j.lrr.2021.100260
Impact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALL
2024 · Blood Advances · 7 citations
https://doi.org/10.1182/bloodadvances.2024013747
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat